Amgen reported $3.77B in Operating Expenses for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Agios Pharmaceuticals AGIO:US $ 91.22M 45.26M
Alexion Pharmaceuticals ALXN:US $ 1000.3M 30.6M
ALKERMES ALKS:US 269.96M 40.76M
Amgen AMGN:US $ 3.77B 854M
Astrazeneca AZN:US 5.43B 498M
Biogen BIIB:US $ 1720.1M 1463.1M
Biomarin Pharmaceutical BMRN:US $ 460.94M 36.01M
Bluebird Bio BLUE:US $ 244M 29.31M
Bristol Myers Squibb BMY:US $ 9.32B 13.58B
Coherus Biosciences CHRS:US $ 250.39M 156.4M
Dicerna Pharmaceuticals DRNA:US $ 76.71M 4.1M
Eli Lilly And LLY:US $ 5650.3M 202.4M
Exelixis EXEL:US $ 274.84M 29.08M
Genmab GEN:DC 1.05B 108M
Gilead Sciences GILD:US $ 3533M 1237M
GlaxoSmithKline GSK:LN 5.72B 1.95B
Glaxosmithkline GSK:US 5.72B 1.95B
Intercept Pharmaceuticals ICPT:US $ 111.01M 12.86M
IONIS PHARMACEUT IONS:US $ 203.58M 109.37M
Johnson & Johnson JNJ:US $ 14.89B 5.94B
Merk MRK:US $ 9038M 5726M
Mirati Therapeutics MRTX:US $ 132.42M 24.38M
Moderna Inc MRNA:US 671M 174.78M
Neurocrine Biosciences NBIX:US $ 205.1M 10.6M
Novartis NVS:US 10.28B 107M
Novartis NOVN:VX 10.28B 107M
Pfizer PFE:US $ 9065M 2442M
Ptc Therapeutics PTCT:US $ 216.09M 852K
Puma Biotechnology PBYI:US $ 78.21M 14.35M
Regeneron Pharmaceuticals REGN:US $ 1416M 160.1M
Sarepta Therapeutics SRPT:US $ 298.8M 17.06M
Seattle Genetics SGEN:US $ 454.4M 18.1M
Teva Pharmaceutical TEVA:IT 3.55B 500M
Ultragenyx Pharmaceutical RARE:US $ 205.96M 18.34M
Vertex Pharmaceuticals VRTX:US $ 836.48M 45.55M
YTE INCY:US $ 505.92M 119.36M